The study is designed to develop an driven empirically, nurse-led method of patient comfort through the ventilator withdrawal process, reducing individual family members and suffering distress. Half a million patients undergo ventilator withdrawal each year Nearly, but there is little empirical evidence to see this common procedure. With no accepted evidence-based guidelines guiding ventilator withdrawal, clinicians depend on intuition, varying levels of experience or customary regional practice.Related StoriesViralytics enters into clinical trial collaboration contract with MSDNew findings reveal association between colorectal cancer and melanoma medication treatmentOvarian cancer patients with a brief history of oral contraceptive make use of have better outcomesTaken together, Antonarakis says, the results, if confirmed in larger trials, suggest that the presence of the AR-V7 variant could possibly be utilized someday as a biomarker to boost treatment decision-making for sufferers with prostate cancer. When some sufferers take either abiraterone or enzalutamide, the drug stops operating, and their tumor grows and spreads, clarifies Antonarakis. The incidence of AR-V7 among these sufferers may be as high as 30 to 40 %, he notes. It will be very helpful to know if such patients are AR-V7-positive, Antonarakis says, because if they were, an improved step for them may be chemotherapy rather than the choice androgen receptor-directed hormonal therapy.